Pfizer’s ‘Industry First’ Warranty Program For Xalkori Available To Medicare Part D Patients
Executive Summary
Pilot program offers Part D beneficiaries an alternative to manufacturer assistance in the form of copay coupons, which are prohibited in government-sponsored health plans. New program also available to commercial insurance and cash-paying patients.
You may also be interested in...
Blazing A Trail? Pfizer’s Warranty Program May Alleviate Medicaid ‘Best Price’ Implications
Pfizer's Xalkori warranty program uses a third party to provide any refunds approved, which would exempt them from best price reporting requirements.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.